211 related articles for article (PubMed ID: 12537701)
21. [Methadone blood assay by the FPIA technique: application to the monitoring of patients in maintenance treatment to opiates].
Boglione-Kerrien C; Furet Y; Bachellier J; Paintaud G; Autret-Leca E
Ann Biol Clin (Paris); 2007; 65(1):51-7. PubMed ID: 17264039
[TBL] [Abstract][Full Text] [Related]
22. Changes to the daily pattern of methadone-related deaths in England and Wales, 1993-2003.
Morgan OW; Johnson H; Rooney C; Seagroatt V; Griffiths C
J Public Health (Oxf); 2006 Dec; 28(4):318-23. PubMed ID: 17060353
[TBL] [Abstract][Full Text] [Related]
23. Deaths in the first two weeks of maintenance treatment in NSW in 1994: identifying cases of iatrogenic methadone toxicity.
Caplehorn JR
Drug Alcohol Rev; 1998 Mar; 17(1):9-17. PubMed ID: 16203464
[TBL] [Abstract][Full Text] [Related]
24. Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test.
Melichar JK; Myles JS; Eap CB; Nutt DJ
Addict Biol; 2003 Mar; 8(1):59-66. PubMed ID: 12745417
[TBL] [Abstract][Full Text] [Related]
25. London audit of drug-related overdose deaths: characteristics and typology, and implications for prevention and monitoring.
Hickman M; Carrivick S; Paterson S; Hunt N; Zador D; Cusick L; Henry J
Addiction; 2007 Feb; 102(2):317-23. PubMed ID: 17222287
[TBL] [Abstract][Full Text] [Related]
26. Unintentional methadone-related overdose death in New Mexico (USA) and implications for surveillance, 1998-2002.
Shah N; Lathrop SL; Landen MG
Addiction; 2005 Feb; 100(2):176-88. PubMed ID: 15679747
[TBL] [Abstract][Full Text] [Related]
27. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
28. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
29. Methadone--a cause of death.
Segal RJ; Catherman RL
J Forensic Sci; 1974 Jan; 19(1):64-71. PubMed ID: 4853192
[No Abstract] [Full Text] [Related]
30. Methadone-related deaths in New South Wales.
Sunjic S; Zador D
Med J Aust; 1997 Jan; 166(1):54-5. PubMed ID: 9006618
[No Abstract] [Full Text] [Related]
31. Pharmacokinetic interaction of nelfinavir and methadone in intravenous drug users.
Hsyu PH; Lillibridge J; Daniels E; Kerr BM
Biopharm Drug Dispos; 2006 Mar; 27(2):61-8. PubMed ID: 16299829
[TBL] [Abstract][Full Text] [Related]
32. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
33. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
[TBL] [Abstract][Full Text] [Related]
34. Postmortem toxicology of drugs of abuse.
Drummer OH
Forensic Sci Int; 2004 Jun; 142(2-3):101-13. PubMed ID: 15172074
[TBL] [Abstract][Full Text] [Related]
35. An unusual case of post-mortem redistribution of ethanol.
Pélissier-Alicot AL; Fornaris M; Bartoli C; Piercecchi-Marti MD; Sanvoisin A; Leonetti G
Forensic Sci Int; 2005 May; 150(1):81-3. PubMed ID: 15837011
[TBL] [Abstract][Full Text] [Related]
36. Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patients.
Uehlinger C; Crettol S; Chassot P; Brocard M; Koeb L; Brawand-Amey M; Eap CB
J Clin Psychopharmacol; 2007 Jun; 27(3):273-8. PubMed ID: 17502774
[TBL] [Abstract][Full Text] [Related]
37. Estimating the total mortality among problem drug users.
Cruts G; Buster M; Vicente J; Deerenberg I; Van Laar M
Subst Use Misuse; 2008; 43(5):733-47. PubMed ID: 18393087
[TBL] [Abstract][Full Text] [Related]
38. Atypical postmortem redistribution in chronic methadone consumers.
Garneau B; Roy C; Motard J; Desharnais B; Bouchard C; Mireault P
J Anal Toxicol; 2024 Jun; 48(5):343-349. PubMed ID: 38491986
[TBL] [Abstract][Full Text] [Related]
39. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
40. The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio.
Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA
Exp Clin Psychopharmacol; 2009 Jun; 17(3):146-53. PubMed ID: 19586229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
